Wordt geladen...
‘Me-Too’ Innovation in Pharmaceutical Markets()
Critics of me-too innovation often argue that follow-on drugs offer little incremental clinical value over existing pioneer products, while at the same time increasing health care costs. We examine whether consumers view follow-on and pioneer drugs as close substitutes or distinct clinical therapies...
Bewaard in:
| Gepubliceerd in: | Forum Health Econ Policy |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5659838/ https://ncbi.nlm.nih.gov/pubmed/29081727 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|